• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[C-erbB3在卵巢移行细胞癌中的过表达]

[Overexpression of C-erbB3 in transitional cell carcinoma of the ovary].

作者信息

Shen K, Lang J, Guo L

机构信息

Peking Union Medical College Hospital, Beijing.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 1995 Nov;30(11):658-61.

PMID:8745489
Abstract

OBJECTIVE

To determine the prevalence of C-erbB3 abnormal protein expression in transitional cell carcinoma of the ovary in our hospital and to analyse the correlation between the overexpression of C-erbB3 protein and prognostic parameters of transitional cell carcinoma of the ovary.

METHODS

Thirty-two transitional cell carcinoma of the ovary and 20 normal ovaries were studied for overexpression of C-erbB3 protein by immunohistochemical staining (IHS), using the monoclonal antibody RJT2 on paraffin sections.

RESULTS

Forty seven percent of 32 samples of transitional cell carcinoma of the ovary showed positive IHS with RJT2, and 39% of 20 normal ovaries showed positive cytoplasmic and membrane staining (P > 0.05). C-erbB3 overexpression did not correlate with age, CA125 levels, histological grade and lymph node metastases, but patients with overexpression of C-erbB3 had a poorer prognosis.

CONCLUSION

Overexpression of C-erbB3 is a common event in transitional cell carcinoma of ovary. Further studies are warranted to clarify the role of C-erbB3 in transitional cell carcinoma of the ovary.

摘要

目的

确定我院卵巢移行细胞癌中C-erbB3异常蛋白表达的患病率,并分析C-erbB3蛋白过表达与卵巢移行细胞癌预后参数之间的相关性。

方法

采用单克隆抗体RJT2,通过免疫组织化学染色(IHS)对32例卵巢移行细胞癌和20例正常卵巢组织石蜡切片进行C-erbB3蛋白过表达研究。

结果

32例卵巢移行细胞癌样本中有47%经RJT2免疫组织化学染色呈阳性,20例正常卵巢组织中有39%呈细胞质和细胞膜染色阳性(P>0.05)。C-erbB3过表达与年龄、CA125水平、组织学分级和淋巴结转移无关,但C-erbB3过表达的患者预后较差。

结论

C-erbB3过表达在卵巢移行细胞癌中较为常见。有必要进一步研究以阐明C-erbB3在卵巢移行细胞癌中的作用。

相似文献

1
[Overexpression of C-erbB3 in transitional cell carcinoma of the ovary].[C-erbB3在卵巢移行细胞癌中的过表达]
Zhonghua Fu Chan Ke Za Zhi. 1995 Nov;30(11):658-61.
2
[Overexpression of p53 in transitional cell carcinoma of the ovary].[卵巢移行细胞癌中p53的过表达]
Zhonghua Fu Chan Ke Za Zhi. 1995 Mar;30(3):153-6.
3
Overexpression of p53, EGFR, c-erbB2 and c-erbB3 in endometrioid carcinoma of the ovary.p53、表皮生长因子受体(EGFR)、c-erbB2和c-erbB3在卵巢子宫内膜样癌中的过表达。
Chin Med Sci J. 1997 Jun;12(2):67-70.
4
Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.转移相关基因nm23-H1和nm23-H2在卵巢癌中的表达:与临床病理、表皮生长因子受体(EGFR)、原癌基因c-erbB-2和c-erbB-3以及性甾体激素受体表达的相关性
Cancer Res. 1994 Apr 1;54(7):1825-30.
5
Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.卵巢癌衍生细胞系和正常人体组织中表达的四种交替c-erbB3转录本的分离与鉴定。
Oncogene. 1998 Jun 25;16(25):3243-52. doi: 10.1038/sj.onc.1201866.
6
Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer.1型酪氨酸激酶生长因子受体表皮生长因子受体、c-erbB2和c-erbB3在膀胱癌中的表达。
J Pathol. 1996 Aug;179(4):381-5. doi: 10.1002/(SICI)1096-9896(199608)179:4<381::AID-PATH603>3.0.CO;2-X.
7
Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study.唾液腺腺样囊性癌中c-erbB家族基因产物的表达:一项免疫组织化学研究。
Anticancer Res. 1995 Nov-Dec;15(6B):2623-6.
8
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.膀胱移行细胞癌中过表达ErbB2、ErbB3或特定ErbB4亚型患者的鉴定:来自癌症患者的ErbB受体状态评估中的实时逆转录PCR分析
Clin Cancer Res. 2003 Nov 1;9(14):5346-57.
9
Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.血吸虫病相关的、器官局限型、肌层浸润性膀胱癌:凋亡标志物、增殖标志物、p53、E-钙黏蛋白、表皮生长因子受体及c-erbB-2的预后价值
J Urol. 2001 May;165(5):1481-7.
10
[Relationship of expression of C-erbB2, C-erbB3, and C-erbB4 with ovarian carcinoma].[C-erbB2、C-erbB3和C-erbB4的表达与卵巢癌的关系]
Ai Zheng. 2004 May;23(5):568-72.

引用本文的文献

1
Pure Transitional Cell Carcinoma of the Ovary Presenting as Bilateral Complex Cystic Masses in a Premenopausal Woman - Case Report and Review of Literature.一名绝经前女性卵巢纯移行细胞癌表现为双侧复杂性囊性肿物——病例报告及文献复习
J Midlife Health. 2019 Jul-Sep;10(3):156-159. doi: 10.4103/jmh.JMH_66_19.
2
Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.水飞蓟宾通过抑制神经调节蛋白/人表皮生长因子受体3信号通路对人卵巢癌细胞生长和侵袭特性的影响
Tumour Biol. 2016 Mar;37(3):3913-23. doi: 10.1007/s13277-015-4220-6. Epub 2015 Oct 19.
3
High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer.
卵巢癌中ErbB3、ErbB4和MET表达的高发生率。
Int J Gynecol Pathol. 2014 Jul;33(4):402-10. doi: 10.1097/PGP.0000000000000081.
4
EGFR/HER-targeted therapeutics in ovarian cancer.表皮生长因子受体/人表皮生长因子受体靶向治疗在卵巢癌中的应用。
Future Med Chem. 2012 Mar;4(4):447-69. doi: 10.4155/fmc.12.11.
5
Transitional cell carcinoma of the ovary: a rare case and review of literature.卵巢移行细胞癌:一例罕见病例并文献复习。
World J Surg Oncol. 2010 Nov 14;8:98. doi: 10.1186/1477-7819-8-98.
6
The ERBB3 receptor in cancer and cancer gene therapy.癌症中的ERBB3受体与癌症基因治疗
Cancer Gene Ther. 2008 Jul;15(7):413-48. doi: 10.1038/cgt.2008.15. Epub 2008 Apr 11.